Aristotle University Of Thessaloniki (AUTH)
Το μεταβολικό σύνδρομο σε υπέρβαρα και παχύσαρκα παιδιά και εφήβους
Abstract
dc:descriptionMetabolic syndrome (MS) is defined as clustering of cardiovascular risk factors with the common pathophysiology of abdominal obesity and insulin resistance. The prevalence and characteristics of MS in children and adolescents have not been extensively studied. Furthermore, its relationship with sub-clinical inflammation, non-alcoholic fatty liver disease (NAFLD) and premature atheromatosis in youth remains to be elucidated. The aim of this study was: 1. To define the prevalence and characteristics of MS in overweight and obese children and adolescents. 2. To diagnose children with prediabetes, hyperinsulinemia, insulin resistance and NAFLD. 3. To investigate the hypothesis that obese and overweight children with MS, compared to their counterparts without metabolic abnormalities, have elevated levels of well established markers of sub-clinical inflammation such as hsCRP, IL-6, TNFa, fibrinogen, adiponectin and homocysteine and run therefore increased cardiovascular risk. A total of 144 children and adolescents, 6-17 year old, were enrolled in this study, classified according to their BMI into three groups. Group A: 54 obese (BMI≥95th PC) children and adolescents (28 female). Group Β: 50 overweight (85th PC ≤ΒΜΙ<95th PC) children and adolescents (30 female). Group C: 40 normal weight (ΒΜΙ<85th PC) healthy children and adolescents (22 female) as control group. Groups A and B consisted of children attending consecutively the childhood and adolescence obesity clinic. The study protocol included the following: Α. History of birth weight, pregnancy duration, breastfeeding duration. B. Family history of Diabetes and reported parental weight and height. C. Puberty stage assessment, according to Tanner definitions, and physical examination for acanthosis nigricans. D. Measurements of weight, height and waist circumference (WC). Assessment of WC percentile according to Fernandez et al standards for USA children and adolescents of european origin. BMI percentile assessment according to the development curves of the A´ Pediatric Department of the University of Athens, applied to greek population. Blood Pressure measurement and assessment of blood pressure percentile based on the development curves of the A´ Pediatric Department of the University of Thessaloniki. Ε. Full Blood Count, fasting lipid profile, liver function tests, thyroid function tests, measurement of fasting insulin, HbA1c measurement, assessment of insulin resistance with HOMA-IR. Oral glucose tolerance test was performed to the obese and overweight children. hsCRP, IL-6, TNFa and fibrinogen were measured as markers of sub-clinical inflammation. Homocysteine was measured as marker of premature atherogenesis and oxidative stress and adiponectin as a potentiate cardioprotective marker. All the obese and overweight children underwent a liver ultrasound for the detection of NAFLD. MS diagnosis was based on Cook criteria modified for an upper normal limit of fasting glucose3.1 and hyperinsulinemia was defined as fasting insulin>20 μU/ml. MS was diagnosed in 31.5% of the obese and in 8% of the overweight children and adolescents. Low HDL-cholesterol and increased triglycerides were the main determinants of the syndrome both in obese (94% and 64.7%, respectively) and overweight (75% each) children and adolescents. Prediabetes (IFG or/and IGT) was diagnosed in 44.4% of the obese and 24% of the overweight children and adolescents. More specifically, 29.6% of the obese and 16% of the overweight children and adolescents had IFG, while the percentage of the obese and overweight children and adolescents with IGΤ was 5.6% και 6% respectively. 9.3% of the obese and 2% of the overweight children and adolescents had both IFG and IGT. NAFLD was diagnosed in 44.4% of the obese and in 18% of the overweight children and adolescents. 79.6% of the obese και το 56% of the overweight children and adolescents were insulin resistant. Moreover, 55.6% of the obese and 34% of the overweight children and adolescents were huperinsulinemic. Obese and overweight children with MS compared to their counterparts without MS had more severe abdominal obesity (WC: 102.0±12.5cm vs 93.2±9.2cm, p=0.005), were more insulin resistant (HOMA-IR: 7.6±5.0 vs 4.5±2.7, p=0.012), had elevated fasting glucose (FG: 100.0±9.7mg/dl vs 94.6±8.7mg/dl, p=0.015), had more atherogenic lipid profile (HDL: 36±7mg/dl vs 48±8mg/dl, p<0.001 and triglycerides: 137±69 mg/dl vs 83±32mg/dl, p=0.002) and elevated markers of sub-clinical inflammation (fibrinogen: 446±91mg/dl vs 389±94mg/dl, p=0.016 and IL-6: 2.9±1.9 vs1.7±1.5, p=0.013). In conclusion MS was quite prevalent in our study especially among severely obese children and adolescents. Low HDL-cholesterol and elevated triglycerides seem to be the main metabolic abnormalities in youths with MS. Furthermore, a concerning number of obese and overweight children and adolescents has also prediabetes, predominantly as IFG, and NAFLD. MS in obese and overweight children and adolescents is related to severe abdominal obesity and insulin resistance, hyperglycemia, atherogenic lipid profile and elevated markers of sub-clinical inflammation such as fibrinogen and IL-6. Therefore, compared to their counterparts without MS, obese and overweight children and adolescents may run additional cardiovascular risk and need more intensive intervention to effectively reduce it.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kitsios, Konstantinos
- Κίτσιος, Κωνσταντίνος
Subjects
dc:subject × 20- Μεταβολικό σύνδρομο
- Προδιαβήτης
- Μη αλκοολική λιπώδης νόσος του ήπατος
- Παχυσαρκία
- Υποκλινική φλεγμονή
- Αδιπονεκτίνη
- Ομοκυστεΐνη
- Ινσουλινοαντίσταση
- Metabolic syndrome
- Prediabetes
- Non-alcoholic fatty liver disease
- Obesity
- Sub-clinical inflammation
- Adiponectin
- Homocysteine
- Insulin resistance
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/33156